GVR Report cover Medical Biomimetics Market Size, Share & Trends Report

Medical Biomimetics Market Size, Share & Trends Analysis Report By Type (Orthopedic, Dental, Cardiovascular), By Application (Tissue Engineering, Drug Delivery), By Region, And Segment Forecasts, 2022 To 2030

  • Report ID: GVR453403
  • Number of Pages: 0
  • Format: Electronic (PDF)

Biomimetics is the fastest developing area of bioengineering. It is the imitation of features found in plants and animals to provide both protection and treatment from illness and bacteria as well as disease management. Medical Biomimetics is considered a technology that uses or emulates nature for the improvement of the lives of humans. Biomimetics comprises principles from chemistry, engineering, and biology, applied to the synthesis of materials, machines, or synthetic systems that consist of functions or operations that mimic biological processes. Biomimetics-based designs are used in tissue engineering, regenerative medicine, and drug delivery. Medical biomimetics is witnessing promising anticipation in the making of surgical devices and instruments. These instruments perform the basic functions like cutting, stinging, and gripping which can be performed by hands, feet, mouth, and other organs.

There is an increasing demand for prostheses and implants for organ transplantation, which is a prominent factor to boost the biomimetics market. Some of the examples are electric eel-inspired power sources for artificial organs. Eel has the ability to produce shock up to 600 volts using concentrated cells. An electric synthetic organ producing 100 volts was built using the combination of hydrogels and salts which could be used to charge medical devices like pacemakers without external recharging. The product ‘Electric Eel’ is manufactured by ‘Electric Eel Manufacturing’ company based in Ohio, U.S. Some other examples are peacock inspires biosensors, gecko inspired surgical glue, octopus inspired sucker for tissue grafting. It is also used in the treatment of disease like Alzheimer’s. Intravenous neuronal tau targeting biomimetic nanoparticles for curcumin delivery is used for the cure of Alzheimer’s.

It is observed that the geriatric population are more prone for organ dysfunction and failure which will stimulate the increased use of biomimetics in devices and tools for organ recreation. This is expected to bring positive impact in the field of organ transplantation in the upcoming years. A rise in the application of medical biomimetics in noninvasive techniques including CT scans, ECGs, and ultrasound in the field of healthcare are projected to drive the growth in the market. The advancements in the field of Nanotechnology, leading to the improvement in drug delivery system will positively impact the market growth in the upcoming years. Recently, Nexa 3D, a 3D printer manufacturer announced a dental prosthetics material xMODEL 2505 for prosthetic use. Although stringent clinical and regulatory requirements could be the restraining factors. Also, Applied Biomimetic (confluent of polymer and protein membrane technologies) has announced inauguration of its new research facilities in Gaithersburg, Maryland., U.S.

The segments are based on product type and application. Some of the popular areas of application are dentistry, cardiology, orthopedics, ophthalmology. Based on application, market can be segmented into wound healing, plastic surgery, drug delivery, and tissue engineering. The drug delivery segment is anticipated to lead the market due to advancements in nanotechnology, which enable accurate and efficient non carrier drug delivery via biomimetic devices. Adequate funding and advancements in research and development will boost growth.

Based on regional analysis, the medical biomimetics market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is a dominating market as the region has a high adoption rate of novel technology, growing geriatric population, rise in research and development activities associated with medical biomimetics, and key players. Asia Pacific is expected to expand at a high growth rate during the forecast period due to factors like an increase in patient population, government initiatives in the healthcare sectors, growth in the biotechnology sector.    

                                Medical Biomimetics Market Segmentation                                          




Cardiovascular, Orthopedic (Bones Biomimetics-calcium-phosphate protein templates), Ophthalmology, Dental (Endodontics, Dental Equipment’s, Restorative Implants )


Wound healing, Tissue Engineering, Drug Delivery, Plastic Surgery, Others


North America (U.S., Canada)

Europe (France, Germany, Italy, Spain, UK),

Asia-Pacific (China, Japan, India, South Korea, Australia),

Latin America (Brazil, Argentina, Mexico)

Middle East & Africa (South Africa, Saudi Arabia, UAE)


Various companies are involved in the mergers, takeovers, organic and inorganic growth strategies and collaborations. These activities have led to the expansion and growth of business. Key players in market include BioHorizons IPH, Inc., Avinent, Biomimetics Technology Inc SynTouch Inc., Wright Medical Group N.V., Veryan Medical, Applied Biomimetic, Blatchford Group (Chas. A. Blatchford & Sons Ltd), and Abbott.

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.